Interestingly, we further compared brain infarct size between perioperative stroke mice with anti-CD8α mAb and stroke-only mice with anti-CD8α mAb and observed no measurable differences between these two groups (P = 0.8075), indicating a therapeutic potential for exacerbated cerebral ischemic brain damage (Fig. 4D). The gene discussed is CD8A; the disease is Stroke.